BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5499122)

  • 1. [Morphological picture of the bone marrow from data of trepanobiopsy of the ilium in patients with erythremia during treatment with cytostatic agents].
    Demidova AV; Khandzhian KG
    Probl Gematol Pereliv Krovi; 1970 Dec; 15(12):28-31. PubMed ID: 5499122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of lymphoproliferative diseases by bone marrow trepanobiopsy specimens].
    Frank GA; Kaplanskaia IB; Glasko EN; Semenov EA; Roshchina LS; Korolev AV
    Arkh Patol; 2007; 69(3):15-8. PubMed ID: 17722588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
    Notario A; Rolandi ML; Mazzucchelli I
    Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow alterations in sarcoidosis].
    Glasko EN; Semenova EA; Korolev AV; Melikian AL; Zvonkov EE; Egorova EK
    Arkh Patol; 2003; 65(6):49-51. PubMed ID: 14964970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete remissions and current treatment of acute leukemia].
    Bernard J
    Probl Gematol Pereliv Krovi; 1965 Nov; 10(11):3-9. PubMed ID: 5873262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone marrow in malignant non-Hodgkin's lymphomas (trephine biopsy data)].
    Kaplanskaia IB; Khokhlova MP
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):28-34. PubMed ID: 7178054
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic experiences with the combination of roentgen rays and a cytostatic agent in model experiments with Jensen sarcoma in rats. III. Morphological studies on the spleen and bone marrow of treated animals].
    SCHERER E; RINGLEB D; SCHOTT H
    Strahlentherapie; 1961 Jun; 115():219-32. PubMed ID: 13747508
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Megaloblastic erythropoiesis in stem cell leukemias].
    Kraus W
    Z Gesamte Inn Med; 1981 Feb; 36(3):82-5. PubMed ID: 7222855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
    Lemancewicz D; Dziecioł J; Kłoczko J; Piszcz J
    Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of outcome by response flawed.
    Anderson JR; Neuberg DS
    J Clin Oncol; 2005 Nov; 23(31):8122-3; author reply 8123-4. PubMed ID: 16258114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of thalidomide in the treatment of multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
    Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
    Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases.
    Millot F; Delval O; Giraud C; Bataille B; Babin P; Germain T; Sadoun A; Vandermarq P; Guilhot F
    Bone Marrow Transplant; 1999 Dec; 24(12):1347-9. PubMed ID: 10627646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observation of bone marrow function in cytostatic treatment of malignant tumors].
    KRATZSCH E; SCHMERMUND HJ
    Med Klin; 1959 Jul; 54(27):1238-40. PubMed ID: 13673975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.